Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment.
de la Prada Álvarez FJ, Cintra Cabrera M, Almenara Tejederas M, Burgos Martin J, Alonso García F, Salgueira Lazo M. de la Prada Álvarez FJ, et al. Among authors: salgueira lazo m. Nefrologia (Engl Ed). 2024 Mar-Apr;44(2):306-307. doi: 10.1016/j.nefroe.2024.03.004. Epub 2024 Apr 16. Nefrologia (Engl Ed). 2024. PMID: 38631964 Free article. No abstract available.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?
Arrobas Velilla T, Guijarro C, Campuzano Ruiz R, Rodríguez Piñero M, Valderrama Marcos JF, Pérez Pérez A, Botana López MA, Morais López A, García Donaire JA, Carlos Obaya J, Castilla Guerra L, Pallares Carratalá V, Egocheaga Cabello I, Salgueira Lazo M, Castellanos Rodrigo MM, Mostaza Prieto JM, Gómez Doblas JJ, Buño Soto A; en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular. Arrobas Velilla T, et al. Among authors: salgueira lazo m. Rev Clin Esp (Barc). 2023 Aug-Sep;223(7):440-449. doi: 10.1016/j.rceng.2023.06.001. Epub 2023 Jun 9. Rev Clin Esp (Barc). 2023. PMID: 37302464
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories.
Arrobas Velilla T, Guijarro C, Campuzano Ruiz R, Rodríguez Piñero M, Valderrama Marcos JF, Botana López AM, Morais López A, García Donaire JA, Obaya JC, Castilla Guerra L, Pallares Carratalá V, Egocheaga Cabello I, Salgueira Lazo M, Castellanos Rodrigo MM, Mostaza Prieto JM, Gómez Doblas JJ, Buño Soto A; en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular. Arrobas Velilla T, et al. Among authors: salgueira lazo m. Endocrinol Diabetes Nutr (Engl Ed). 2023 Aug-Sep;70(7):501-510. doi: 10.1016/j.endien.2023.05.012. Epub 2023 Jun 1. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 37268528
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?
Arrobas Velilla T, Guijarro C, Campuzano Ruiz R, Rodríguez Piñero M, Valderrama Marcos JF, Pérez Pérez A, Botana López MA, Morais López A, García Donaire JA, Obaya JC, Castilla Guerra L, Pallares Carratalá V, Egocheaga Cabello I, Salgueira Lazo M, Castellanos Rodrigo MM, Mostaza Prieto JM, Gómez Doblas JJ, Buño Soto A; en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular. Arrobas Velilla T, et al. Among authors: salgueira lazo m. Clin Investig Arterioscler. 2023 Mar-Apr;35(2):91-100. doi: 10.1016/j.arteri.2022.10.002. Epub 2023 Mar 14. Clin Investig Arterioscler. 2023. PMID: 36925360 Free article. English, Spanish.
Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis.
Almenara-Tejederas M, Alonso-García F, Aguillera-Morales WA, de la Prada-Álvares F, Salgueira-Lazo M. Almenara-Tejederas M, et al. Among authors: salgueira lazo m. Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):28-32. doi: 10.1016/j.nefroe.2022.02.003. Epub 2022 Feb 16. Nefrologia (Engl Ed). 2022. PMID: 36153896 Free article.
30 results